Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03123419

Gardasil Administration

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
St. Louis University · Academic / Other
Sex
Female
Age
9 Years – 26 Years
Healthy volunteers
Not accepted

Summary

The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.

Detailed description

Patients will be screened in center for history of Gardasil vaccination. If the patient has not received the vaccination series they will be counseled/educated (standard of care \[SOC }) and offered the vaccine series. If the patient agrees to the vaccination, they will then be offered participation in this study, (consent will be reviewed and signed) and they will receive the first vaccination at this visit, administered according to standard protocol. The patient will then be scheduled for two follow up vaccination appointments. The second vaccination will be given 2 months after the first vaccine and the third will be given 4 months after the second vaccination in accordance with the Gardasil vaccine guidelines. -SOC The patients will receive a total of two texts during the study entirety. The two texts will be appointment reminders for the second and third vaccination, sent 1 week prior to the next appointment. This is study related. Data collection Data will be collected using a data collection sheet. The investigators will record date of first vaccine administration and adherence to follow up.vaccinations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAppointment remindersThe purpose of the Gardasil study is to increase the rates of Gardasil vaccination in the Maternal Fetal Care Center. This will be done by reminding patients via text to come for their follow up vaccine appointments.

Timeline

Start date
2018-02-01
Primary completion
2019-03-01
Completion
2019-04-01
First posted
2017-04-21
Last updated
2018-03-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03123419. Inclusion in this directory is not an endorsement.